ClinicalTrials.govpublic full text
TDF Dose Adjustment VS. Switching to TAF in TDF-experienced CHB Patients With Renal Impairment
renal insufficiency, tenofovir, tenofovir disoproxil fumarate, tenofovir alafenamide, tdf, taf, renal, impairment, insufficiency, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 885821
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.